Next-Generation Sequencing – Products

Collaboration aims to provide researchers cutting-edge tools to enable transformational monitoring of key biomarkers in solid tissue transplants.

With the announcement of a $500,000 donation to the UCSC Genomics Institute in support of the UCSC Paleogenomics Lab, Colossal continues to expand its ancient DNA academic collaborations.

Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.

Innovative Hi-C-like technique shows enhanced sensitivity for detecting structural variants and chromatin topology features in cancer.

Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.

Revolutionary genomic research applied an innovative use of multiomics and biomimetic digital twins to unveil new DNA variants associated with the development of endometrial related disorders.

This application note explores an optimized RNA-sequencing workflow that reliably determines cell subset abundance and cell-type-specific gene expression profiles from bulk tissue or blood expression data.

This application note explores the performance characteristics of a tissue panel for profiling both FF and FFPE tissue samples using a state-of-the-art software solution for digital cytometry.

HiFi data generated on the Revioä system will support the EU and Estonian government-funded Center for Personalized Medicine and unlock discoveries across cardiology, mental and reproductive health, drug response, cancer research and rare diseases.

Designed to build the foundation for diagnosing rare diseases in the future. Ability to perform workflow analysis through in-house global laboratory network.